What is Sinovac's ticker symbol and on what exchange does it trade?
Sinovac Biotech, Ltd. trades on the NASDAQ Global Market under the ticker symbol "SVA".
Where is Sinovac headquartered?
Sinovac's principal executive offices are located at:
No. 39 Shangdi Xi Road,
Haidian District, Beijing 100085
People’s Republic of China
When and where was the Company incorporated?
Sinovac Biotech Ltd. was incorporated on March 1, 1999 in Antigua and Barbuda.
When does Sinovac's fiscal year end?
Sinovac operates on a December 31 fiscal year end.
Who is Sinovac's independent auditor?
The Company's independent auditor is Ernst and Young.
Who is on Sinovac's Board of Directors?
To view a complete Board list with biographies, click on the Board of Directors link in the Investors section of the Company's Web site.
Does Sinovac currently pay a dividend on its common stock?
Sinovac does not currently pay a dividend on its common stock.
Does Sinovac offer a direct stock purchase plan?
The Company does not currently offer a direct stock purchase plan.
How can I find information on Sinovac’s SEC filings?
Sinovac files periodic reports with the SEC, including:
Annual Report on Form 20-F
Semi-Annual Reports on Form 6-K
Theses filings can be obtained from the SEC Filings link on the Investors section of the Company Web site or by visiting www.sec.gov.
What is Sinovac's CUSIP number?
The Company's CUSIP number is P8696W104.
How can I be placed on the Sinovac's e-mail news distribution list?
To be placed on the Company's e-mail news distribution list, please visit the Contact Us link on the Company Web site.
How can I obtain additional financial or investor information on Sinovac?
Current or potential investors that wish to obtain more information about Sinovac Services should visit the Contact Us link on the Company’s Web site.
Who handles investor relations for Sinovac?
ICR Inc. is Sinovac’s investor relations agency of record. For additional investor information, please refer back to the Investors page of the Company’s Web site.
How do I access Sinovac’s financial results?
Sinovac reports its financial results on a semi-annual basis and files them on Form 20-F or Form 6-K with the SEC.